Buyer's guide / Due diligence

How to Spot Unreliable Research-Peptide Suppliers.

Updated October 2026 · 8 minute read

Every peptide community asks the same question first: how do I know I won't get scammed? This guide collects what peer-reviewed studies found when they actually tested products bought from online sellers, what official consumer-protection agencies say to look for, and the checks you can run yourself before spending anything.

Research information only. This article summarises published research and official consumer guidance. It is not medical advice, not legal advice, and not a statement about any specific seller. Laboratory reference materials are not medicines and are not presented as suitable for human use.

01 / Overview

Why this matters

Independent test purchases of peptides sold online have found products whose measured purity was a fraction of the labelled claim.[7]

In one 2024 peer-reviewed study of online semaglutide, measured purity ranged from under 8% to about 14% against 99% label claims, with endotoxin detected in every tested sample. The gap between label and content is not theoretical.[2]

This guide is about the checks that close it: what the evidence shows, which warning signs deserve scrutiny, and what you can verify before money changes hands.

02 / Evidence

What independent testing has found

The strongest evidence about online peptide quality comes from studies that actually bought products and tested them. The table below summarises what published, peer-reviewed test purchases found.

Study	What was tested	What it found
JMIR, 2024	Semaglutide products bought from online sellers without prescription, analysed by LC-MS and microbiology	Measured purity of 7.7%–14.37% versus 99% claimed on labels, plus detectable endotoxin in all samples
Talanta, 2018	Falsified polypeptide products acquired via illegal internet pharmacies, tested by mass spectrometry	Heavy-metal and elemental impurities, including arsenic above parenteral limits in some samples
Peer-reviewed review, 2026	Gray-market peptide access via clinics and social-media-linked sellers	Uncertain identity, variable purity, contamination, non-sterility, and dosing errors identified as interacting risk pathways; COAs and purity claims noted as no substitute for regulatory review
WHO fact sheet, 2024	Global monitoring of substandard and falsified medical products	At least 1 in 10 medicines in low- and middle-income countries are substandard or falsified, with an estimated US$30.5 billion annual cost

These studies examined products purchased from online sellers, not any specific supplier. They are best read as evidence of what can go wrong when products bypass quality systems — which is the risk a careful buyer is managing.[1], [2], [3]

03 / Warning signs

Signals that deserve scrutiny

No single signal proves a supplier is unreliable. But each one removes a way for you to verify what you are buying — and they tend to cluster.[5], [6]

Prices that don't add up

FDA consumer guidance lists prices "too good to be true" among the classic warning signs of unsafe online sellers. Synthesis, testing, and cold-chain handling all cost money — see our pricing guide for what the record shows about where those costs come from.

No verifiable quality documentation

A 2026 review of gray-market peptide access notes that certificates of analysis and purity claims on product listings do not substitute for regulatory review or manufacturing oversight. A listing that offers no COA — or one you cannot match to a batch — offers nothing to verify.

No physical address, no contactable person

FDA's BeSafeRx guidance warns that unsafe sellers use fake storefronts to mimic legitimate operations, and lists the absence of licensing and of staff who can answer questions among its warning signs. The same logic applies to any online purchase: an untraceable seller is an unaccountable one.

Pressure marketing around health outcomes

The FDA has issued warning letters to online peptide sellers whose websites marketed research-labelled compounds in ways indicating intended human use, calling such products unapproved drugs. Health-outcome marketing paired with "research only" labels is a documented enforcement pattern — and a signal about how seriously the seller takes its own labels.

None of these signals alone proves a seller is unreliable. Together, they are the documented patterns regulators and researchers flag when sellers operate outside quality systems.[4]

04 / Practical checks

Checks you can run before buying

Demand a batch-matched COA before you pay

Ask whether the certificate's batch number will match the vial you receive, and whether the underlying chromatogram is available. A seller who can answer both has something to verify; one who cannot has only marketing.

Search the seller's name independently

The U.S. FTC advises searching a seller's name and web address alongside words like "review", "complaint", and "scam" across several independent sources — and warns that star ratings can be manipulated, so one good rating page is not evidence.

Keep your records

FTC guidance recommends keeping receipts, order confirmations, and the terms you were shown. If anything goes wrong, your evidence is whatever you saved — not what the website said at the time.

Prefer traceable payment paths

The FTC notes paying by credit card carries dispute protections that many alternatives lack. However a seller wants to be paid, ask yourself what recourse exists if the vial doesn't match the document.

Ask where the material is and how it's handled

Many lyophilised peptides need temperature-controlled storage and shipping. "Where does it ship from, and how is it stored?" is a question a real operation answers in a sentence.

These checks mirror the consumer-protection steps official agencies recommend for online purchases generally; they don't replace independent laboratory verification of the material itself.[6]

05 / Trust

What a trustworthy supplier looks like

Trustworthy suppliers make verification easy: batch-specific COAs with chromatograms, named testing laboratories, consistent labelling and marketing, reachable customer support, and honest framing of what their products are.

They answer questions with documents rather than assurances. When you ask which batch a COA belongs to, the answer matches the vial in your hand.

None of that is exotic — it is what documentation looks like when it was made for measurement rather than marketing.

Browse the catalogue

Shop the catalogue

06 / Quick answers

Frequently asked questions

How common are fake or substandard products from online sellers?

Peer-reviewed analyses of products bought from online sellers have documented large gaps between label claims and measured content — one 2024 study measured 7.7%–14.37% purity on products labelled 99% — and the WHO estimates at least 1 in 10 medicines in low- and middle-income countries are substandard or falsified. The scale of the problem is why buyers rely on documentation and verification.

Is a COA on a product page enough?

A COA is evidence, not proof — and only if it is batch-specific, dated, and complete. A 2026 review notes that COAs and purity claims on listings don't substitute for regulatory review. Our COA guide walks through what a strong one contains.

What's the single biggest red flag?

There isn't one — but the strongest pattern is unverifiability: no batch number, no chromatogram, no traceable address, no records. Scams work by removing your ability to check. Anything that restores your ability to check (batch-matched documents, independent testing, traceable payment) works against that.

Are expensive suppliers automatically trustworthy?

No. Price tells you what the seller charges, not what the material contains. Verification — batch-matched analytical records and, where possible, independent testing — is the only check that speaks to the product itself.

What if a seller markets 'research' products with before-and-after health photos?

That combination is a documented enforcement pattern: the U.S. FDA has issued warning letters to online peptide sellers marketing research-labelled compounds in ways indicating intended human use, treating them as unapproved drugs. Whatever a buyer's intention, a seller whose marketing contradicts its own labels is telling you how it treats its other obligations.

07 / Sources